Steroid-Induced Osteonecrosis in Dermatology Journal Articles

abstract

• Background: Steroid-induced osteonecrosis is unpredictable and highly morbid. Methods: MEDLINE (Ovid) and PubMed search for relevant literature. Results: Oral steroid doses typically considered to be associated with the condition are >20 mg of prednisone (or equivalent) per day or >2 g within a period of 2 to 3 months. Symptoms may be vague. Conclusions: Dermatologists must exercise a high degree of clinical suspicion and warn patients about steroid-related risks and conditions for follow-up.

authors

• Nowak, Dominik
• Yeung, Jensen

status

• published 

publication date

• July 2015

has subject area

• Humans (MeSH)
• Osteonecrosis (MeSH)
• Risk Factors (MeSH)
• Steroids (MeSH)

published in

• Medical and Surgical Dermatology  Journal

keywords

• Humans
• Osteonecrosis
• Risk Factors
• Steroids
• aseptic necrosis
• avascular necrosis
• bone death
• corticosteroids
• dermatology
• glucocorticosteroids
• ischemic necrosis
• osteochondritis dissecans
• osteonecrosis
• steroids

Digital Object Identifier (DOI)

• 10.1177/1203475415579759

PubMed ID

• 25825195

start page

• 358

end page

• 360

volume

• 19

issue

• 4